What is SD PharmLabs?
Founded in 2011, SD PharmLabs has established itself as a pioneer in testing services for the cannabinoid, psychedelic, and select nutraceutical industries. The company is dedicated to ensuring product quality, safety, and compliance across both regulated and non-regulated markets. PharmLabs differentiates itself through a white-glove service model, offering live assistance and personalized, competitive pricing designed to support client operational efficiency and growth. Their commitment to accuracy is reinforced by rigorous process verification and a responsive Client Care Team, ensuring timely resolution of any concerns. Fast turnaround times, including same-day testing options, further enhance their value proposition.
How much funding has SD PharmLabs raised?
SD PharmLabs has raised a total of $64K across 1 funding round:
Debt
$64K
Debt (2021): $64K with participation from PPP
What's next for SD PharmLabs?
With substantial expansion capital at a significant Series B/C stage, SD PharmLabs is poised for accelerated growth. This strategic investment is expected to fuel the enhancement of its testing capabilities, potentially expanding its service offerings and market reach. The company's focus on quality, safety, and customer-centric solutions positions it to capitalize on the evolving demands within the cannabinoid, psychedelic, and nutraceutical testing landscape. Future developments may include technological advancements in testing methodologies and broader industry partnerships to solidify its market leadership.
See full SD PharmLabs company page
